Transforming Care Through Next Generation Therapies in Diabetic Macular Edema to Lower Burden and Improve Outcomes
Webinar/Online
Wednesday, February 26, 2025 at 7:30pm CT - 8:30pm CT
Add this event to your calendar
Info
Topic
Diabetes
Credits Offered
This event offers
1.0 CME credit
to attendees.
Accreditation Info:
Accreditation Council for Continuing Medical Education.
Additional Information
On February 26th at 7:30pm CST, Dr. Sunir J. Garg, Professor of Ophthalmology at Wills Eye Hospital and partner with Mid Atlantic Retina, will present "Transforming Care Through Next Generation Therapies in Diabetic Macular Edema." Dr. Garg will share his expertise on advancements in DME treatment, focusing on reducing patient burden, improving adherence, and optimizing outcomes. Attendees will explore barriers to treatment, including injection frequency and patient factors, and review the effectiveness of both established and emerging therapies. The session will also cover personalized care strategies, helping practitioners identify patients eligible for dosing modifications or longer-lasting therapies. This is an essential talk for healthcare professionals seeking to enhance DME management through cutting-edge approaches.
Speakers
Dr. Garg is Professor of Ophthalmology at the Retina Service of Wills Eye Hospital, Thomas Jefferson University, and is a partner with Mid Atlantic Retina. He is co-director of the Retina Research Unit at Wills Eye Hospital and serves as principal investigator on many clinical trials.His clinical interests include advanced treatments for diabetic retinopathy, age-related macular degeneration, complex retinal detachments, retinal vascular diseases, surgical diseases of the macula and retina, and ocular inflammation. Dr. Garg is listed among "The Best Ophthalmologists" in the United States.
Event Agenda
Transforming Care Through Next Generation Therapies in Diabetic Macular Edema to Lower Burden and Improve Outcomes
Event Agenda
Wednesday, February 26, 2025 at 7:30pm CT - 8:30pm CT
All times listed in
Central Time (US & Canada).
Download event agenda (PDF)
Wednesday, February 26, 2025
-
7:30pm - 8:30pm
Transforming Care Through Next Generation Therapies in Diabetic Macular Edema to Lower Burden and Improve Outcomes
Sunir J. Garg, MD, FACS
1.0 CE CreditLearning Objectives:
- Evaluate adherence barriers in DME treatment, including injection frequency and patient factors
- Analyze the duration of effectiveness in established and emerging therapies for DME
- Identify patients eligible for dosing modifications or transitioning to longer-lasting therapies, based on individual, treatment, and disease considerations
- Apply optimal treatment selection and dosing strategies to personalize care for DME patients